Eli Lilly (LLY) stock in focus as an expert panel of the EU drug regulator declines to endorse its Alzheimer's drug Kisunla.

A bioengineer highlights the potential of low-intensity ultrasound for multiple uses, from enhanced drug delivery to the ...

Coleen Nolan suffered in agony watching her mum succumb to Alzheimer's and has now urged her own children not to watch her ...

The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the risk of serious brain ...

Other research is also looking at how lifestyle factors may be able to treat the disease. Take, for example, a systematic ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

As we wait for a breakthrough that can block or reverse Alzheimer’s disease, there is some consolation that we finally have three kinds of medications and a treatment that can ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Crosswords and sardines are great, but there are other ways to stay sharp into old age. And it’s never too early to start.

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Family members interviewed in the program, include NFL Hall of Famer and Super Bowl champion, Randy White, who describes the ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...